Mercury Pharmaceuticals

EULAR project reveals large disparities in European rheumatology care

Rheumatic and musculoskeletal diseases (RMD) are responsible for significant disability, and result in long-term work loss or early retirement.

Novel biomimetic peptide actively rebuilds damaged tooth dentin

Dentin hypersensitivity affects millions of people worldwide, yet existing treatments often provide only temporary relief.

Alzheimer’s disease biomarkers predict rapid cognitive decline in very old adults

Cognitive decline in very old adults has been considered for decades to be an almost inevitable consequence of aging.

Personalized self-management effectively prevents chronic back pain

Almost everyone will deal with back pain at some point in their lives. Most recover quickly - but for about 20% of people, acute pain becomes a chronic condition that interferes with daily life and keeps them out of the workforce.

Scientists map how chronic stress alters somatostatin levels in the brain

Consider the brake. Not the engine, which gets all the attention, but the brake, the quiet thing that decides how fast a system is allowed to go.

New bacterial enzyme blueprint could accelerate cancer treatment development

A team of researchers at the University of Warwick and Monash University has solved a puzzle that's stumped drug developers for decades: how bacteria naturally create multiple versions of powerful cancer therapies.

Advanced brain interfacing technology for both touch and vision restoration

Patients with untreatable conditions such as sight loss or loss of motor-function could be closer to a viable technology for restoring their lost sense, within a faster time frame.

Alexandre Detappe wins ERC grant for nanomedicine-based cancer immunotherapy

The ERC (European Research Council) Proof of Concept grant awarded to Alexandre Detappe (Gustave Roussy/Institut Strauss/Université Paris-Saclay/Inserm) will fund the Nano-BITE project, which aims to improve the ability of the immune system to fight solid tumors through nanomedicine.

Cancer's biggest treatment challenge may be getting solved 250 miles above Earth

For more than two decades, precision oncology has been promoted as the future of cancer treatment, matching therapies to the unique biology of a patient's tumor.

New national program targeting harmful and unnecessary medicine use in Australia